Janux Therapeutics, Inc.
SEC CIK 1817713 · JANX · last insider filing 2026-06-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dobmeier Eric | Director | filed 2024 - 2026 |
| Capps Vickie L | Director | filed 2021 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2021 - 2026 |
| Barrett Ronald W | Director | filed 2021 - 2026 |
| RA Capital Management, LLC | Director | filed 2021 - 2026 |
| Kolchinsky Peter | Director | filed 2021 - 2026 |
| Shah Rajeev M. | Director | filed 2021 - 2026 |
| Kung Winston | Director | filed 2022 - 2026 |
| Hernday Natasha | Director | filed 2024 - 2026 |
| RA Capital Nexus Fund II, L.P. | Director | filed 2023 - 2026 |
| Simson Jake | Director | filed 2021 - 2026 |
| Campbell David Alan | Director · President and CEO | filed 2021 - 2026 |
| Gujrathi Sheila | Director | filed 2021 - 2025 |
| Mcnulty Alana B. | Director | filed 2021 - 2025 |
| Lichter Jay | Director | filed 2021 - 2024 |
| Thompson Peter A. | Director | filed 2021 - 2022 |
| Heller Stefan | Director | filed 2021 - 2022 |
| Orbimed Advisors LLC | Director | filed 2021 - 2021 |
| Orbimed Genesis GP LLC | Director | filed 2021 - 2021 |
| Orbimed Capital GP Viii LLC | Director | filed 2021 - 2021 |
| Orbimed Capital GP VII LLC | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | filed 2025 - 2026 |
| Dobek Maria | Vice President, Accounting | filed 2024 - 2026 |
| Go William | Chief Medical Officer | filed 2026 - 2026 |
| Meyer Andrew Hollman | Chief Business Officer | filed 2021 - 2026 |
| Winter Charles M. | Chief Technical Officer | filed 2023 - 2026 |
| Diraimondo Thomas | Chief Scientific Officer | filed 2024 - 2026 |
| Mciver Zachariah | Chief Medical Officer | filed 2025 - 2026 |
| Robinson Byron | Chief Strategy Officer | filed 2022 - 2025 |
| Reardon Tighe | Acting Chief Financial Officer | filed 2021 - 2024 |
| Godfrey Wayne | Chief Medical Officer | filed 2021 - 2023 |
| Salek-Ardakani Shahram | Chief Scientific Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.